United States: FY 2017 IPPS Proposed Rule Results In Modest Increase For Hospitals

CMS recently issued a proposed rule updating fiscal year (FY) 2017 Medicare payment policies and rates under the Medicare inpatient prospective payment system (IPPS) and the long-term care hospital (LTCH) prospective payment system. Highlights of the proposed rule applicable to IPPS hospitals are the focus of this summary. With the proposed rule, CMS continues to emphasize its focus on quality initiatives and takes significant steps toward alignment of these programs. Comments on the proposed rule are due by June 17, 2016. Once finalized, the updated IPPS will apply to discharges on or after October 1, 2016.

Update to Prospective Payment Rate

Overall, CMS estimates the proposed rule will increase IPPS rates by 0.85 percent in FY 2017, after accounting for inflation and other adjustments required by law. With this increase, hospitals will receive an estimated $539 million more under IPPS than they did in FY 2016. As in previous years, many of these adjustments are closely tied to participation in quality-of-care programs.

Two-Midnight Reduction Reversed

The two-midnight rule established in the FY 2013 IPPS update, created a time-based threshold based on the admitting physician's anticipated length of stay. CMS proposes to drop the inpatient payment cuts originally used to offset the rule and will provide a temporary positive adjustment in FY 2017 to address the retroactive effects of the cuts in FYs 2014, 2015 and 2016.

Hospital Readmissions Reduction Program (HRRP)

For FY 2017 and subsequent years, CMS proposes to use the hospital's risk-adjusted readmission rate during a three-year period for the following measures:

  • Acute myocardial infarction
  • Heart failure
  • Pneumonia
  • Chronic obstructive pulmonary disease
  • Total hip arthroplasty/total knee arthroplasty
  • Coronary artery bypass graft (CABG)

The proposed FY 2017 applicable period will include Medicare Provider Analysis and Review claims with discharge dates from July 1, 2012 through June 30, 2015. CMS clarified that excess readmission rates will be publicly reported on the Hospital Compare website following the preview period. CMS is not putting forward any changes to the HRRP measures in the FY 2017 IPPS rule, declining to incorporate any sociodemographic adjustment into the HRRP's measure. The regulatory impact analysis suggests that refinement of the pneumonia measure and addition of CAGB present the greatest financial impact.

Hospital Value-Based Purchasing (VBP) Program

Several changes would affect the VBP program, including the addition of two condition-specific payment measures (one for acute myocardial infarction and one for heart failure) beginning with the FY 2021 program year and a 30-day mortality measure following CABG surgery beginning with the FY 2022 program year.

CMS proposes to include the catheter-associated urinary tract infections and central line-associated bloodstream infections measures from non-ICU locations for the Hospital VBP Program beginning with the FY 2019 program year, with a baseline period of January 1, 2015, through December 31, 2015, and a performance period of January 1, 2017, through December 31, 2017. CMS proposes to shorten the performance period for the PSI 90 measure for the FY 2018 program year. Beginning with the FY 2019 program year, the Patient- and Caregiver-Centered Experience of Care/Care Coordination domain will change to Person and Community Engagement.

The agency further proposes to modify the definition of a survey-related immediate jeopardy for purposes of Hospital VBP eligibility. Under the proposal, a hospital must incur at least three (previously two) immediate jeopardy citations during the performance period to be excluded from the program. With respect to EMTALA-related immediate jeopardy citations, CMS is proposing to change the date of the immediate jeopardy citation for exclusion purposes to the date of CMS's final issuance of Form CMS-2567 to the hospital.

Hospital Acquired Condition (HAC) Reduction Program

CMS is proposing to make five changes to existing HAC Reduction Program policies:

  • Create NHSN (National Healthcare Safety Network) CDC hospital-acquired infection data submission requirements for newly-opened hospitals.
  • Clarify data requirements for Domain 1 scoring. To receive a Domain 1 score, a hospital must have three or more eligible discharges for at least one component indicator and 12 months or more of data.
  • Establish performance periods for the FY 2018 and FY 2019 HAC Reduction Programs.
  • Adopt the refined PSI 90: Patient Safety for Selected Indicators Composite Measure (NQF # 0531). This modification is a response to NQF (National Quality Forum) concerns and will be adopted for the FY 2018 payment determination and beyond.
  • Adjust the scoring methodology from the current decile-based scoring. Under the new methodology, hospitals would receive a score for each measure that compares performance to the national mean.

Reduction in Disproportionate Share Hospital (DSH) Payments

The proposed rule sets out adjustments to the new DSH formula designed to reflect the growth of insurance coverage. For FY 2017, the amount available for additional uncompensated care payments will decline from 75 percent to 56 percent of the Medicare DSH funds that hospitals would have received under the old DSH formula. In addition, CMS proposes a change in how DSH payment distribution is determined. Over a three-year period beginning in FY 2018, CMS plans to transition away from basing payments exclusively on the hospital's share of Medicare SSI and Medicaid-insured low-income patient days to incorporating the uncompensated care estimate from Worksheet S-10. CMS estimates the FY 2017 updates will amount to a 0.3 percent reduction in Medicare DSH payments and uncompensated care payments, a cut of $400 million in overall DSH payments compared with FY 2016.

Hospital Inpatient Quality Reporting (IQR) Program

The Hospital IQR program proposals present a significant move toward reporting all measures electronically for calendar year (CY) 2017. CMS has also proposed a validation strategy for electronic Clinical Quality Measures (eCQMs).

Several changes are proposed to the existing Hospital IQR measure set. Specifically, four new claims-based measures (three clinical episode-based payment measures and one communication and coordination-of-care measure) are proposed and 15 measures (13 eCQMs and two structural) will be removed for the FY 2019 determination and beyond. These eCQMs will be removed from both the IQR and the electronic health record (EHR) incentive program. CMS is also proposing refinements to two claims-based measures: (1) PN Payment: Hospital-Level, Risk-Standardized 30-Day Episode-of-Care Payment Measure for Pneumonia; and (2) PSI 90: Patient Safety and Adverse Events Composite.

As a signal of alignment with the EHR incentive program, hospitals would be required to (1) submit data for an increased number of eCQMs and (2) report a full year of eCQM data beginning with the CY 2017 reporting period. CMS also clarified that for ED-1, ED-2, VTE-6 and PC-01, hospitals must submit a full year of chart-abstracted data regardless of whether the data is submitted electronically. Hospitals will be required to submit eCQM data two months following the close of the reporting period calendar year for the CY 2017 reporting period.

CMS further proposes to incorporate eCQM validating into the Hospital IQR Program. The proposed rule provides that a random sample of up to 200 hospitals will be selected for validation of eCQMs beginning in spring of CY 2018. If a hospital is selected for chart-abstracted targeted or random validation that hospital would be excluded from the eCQM validation sample. CMS estimates these changes will result in total hospital costs of $30 million.

Finally, CMS is proposing changes to its extraordinary circumstances exception (ECE) policy by (1) extending the general ECE request deadline for non-eCQM circumstances from 30 to 90 calendar days following an extraordinary circumstance, and (2) establishing a separate submission deadline for ECE requests related to eCQM reporting circumstances of April 1 following the end of the reporting calendar year.

Implementation of Notice of Observation Treatment and Implication of Care Eligibility Act

As part of the Notice of Observation Treatment and Implication of Care Eligibility (NOTICE)Act signed into law on August 6, 2015, the proposed rule would require hospitals and critical access hospitals to furnish a new CMS-developed standardized notice, the Medicare Outpatient Observation Notice (MOON), to Medicare beneficiaries or enrollees who have been receiving observation services for more than 24 hours. The MOON will inform beneficiaries of their status as outpatients receiving observational services and explain the implications of observation services on cost-sharing and eligibility for Medicare coverage of skilled nursing facility services.

CMS has proposed the following delivery requirements for the MOON:

  • Must be provided no later than 36 hours after observation services are initiated or sooner if the individual is transferred, discharged or admitted as an inpatient.
  • An oral explanation must be provided with the delivery of the written notice.
  • The beneficiary, or an individual qualified to act on his or her behalf, must sign the notice to acknowledge its receipt and understanding of the notice. If refused, the staff member who presents the notice to the beneficiary must sign and provide additional information regarding the signature dismissal.

CMS plans to release a proposed draft of the MOON for comment soon.

Other Proposals

The proposed rule also addresses other programs and changes, including (1) changes to payments for hospitals and hospital units excluded from the IPPS; (2) cost report regulations to correct technical changes and typographical errors in 42 CFR pt. 413; (3) changes to the wage index; and (4) graduate medical education payments.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.